{"id":"https://openalex.org/W14064228","doi":null,"title":"Tender systems for outpatient pharmaceuticals in the European Union: Evidence from the Netherlands, Germany and Belgium","display_name":"Tender systems for outpatient pharmaceuticals in the European Union: Evidence from the Netherlands, Germany and Belgium","publication_year":2009,"publication_date":"2009-10-01","ids":{"openalex":"https://openalex.org/W14064228","mag":"14064228"},"language":"en","primary_location":{"id":"mag:14064228","doi":null,"is_oa":false,"landing_page_url":"https://ec.europa.eu/DocsRoom/documents/7607/attachments/1/translations/en/renditions/pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062250544","display_name":"Panos G. Kanavos","orcid":"https://orcid.org/0000-0001-9518-3089","observed_orcids":["https://orcid.org/0000-0001-9518-3089"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Panos Kanavos","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9518-3089","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Elizabeth Seeley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth Seeley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5034056717","display_name":"Sotiris Vandoros","orcid":"https://orcid.org/0000-0002-9458-4988","observed_orcids":["https://orcid.org/0000-0002-9458-4988"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sotiris Vandoros","raw_affiliation_strings":["School of Management & Business"],"raw_orcid":"https://orcid.org/0000-0002-9458-4988","affiliations":[{"raw_affiliation_string":"School of Management & Business","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":10.9807,"has_fulltext":false,"cited_by_count":53,"citation_normalized_percentile":{"value":0.97911648,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11531","display_name":"Healthcare Systems and Reforms","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-reimbursement","display_name":"drug reimbursement","score":0.4959999918937683},{"id":"https://openalex.org/keywords/health-insurance-funds","display_name":"health insurance funds","score":0.6890000104904175},{"id":"https://openalex.org/keywords/direct-and-indirect-benefits","display_name":"direct and indirect benefits","score":0.4830000102519989},{"id":"https://openalex.org/keywords/physician-incentives","display_name":"physician incentives","score":0.6499999761581421},{"id":"https://openalex.org/keywords/generic-drugs","display_name":"generic drugs","score":0.5640000104904175},{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.3840000033378601},{"id":"https://openalex.org/keywords/netherlands","display_name":"Netherlands","score":0.6909999847412109},{"id":"https://openalex.org/keywords/germany","display_name":"Germany","score":1.0},{"id":"https://openalex.org/keywords/belgium","display_name":"Belgium","score":1.0}],"concepts":[{"id":"https://openalex.org/C2777488495","wikidata":"https://www.wikidata.org/wiki/Q1742093","display_name":"Remuneration","level":2,"score":0.7602585554122925},{"id":"https://openalex.org/C2910001868","wikidata":"https://www.wikidata.org/wiki/Q458","display_name":"European union","level":2,"score":0.6247748136520386},{"id":"https://openalex.org/C29122968","wikidata":"https://www.wikidata.org/wiki/Q1414816","display_name":"Incentive","level":2,"score":0.5919812321662903},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.5588659644126892},{"id":"https://openalex.org/C100406419","wikidata":"https://www.wikidata.org/wiki/Q3543802","display_name":"Formulary","level":2,"score":0.547387957572937},{"id":"https://openalex.org/C2778030619","wikidata":"https://www.wikidata.org/wiki/Q7180762","display_name":"Pharmaceutical policy","level":4,"score":0.5377910137176514},{"id":"https://openalex.org/C2781249084","wikidata":"https://www.wikidata.org/wiki/Q908656","display_name":"Preference","level":2,"score":0.5048685669898987},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.4916420578956604},{"id":"https://openalex.org/C100001284","wikidata":"https://www.wikidata.org/wiki/Q2248246","display_name":"Public economics","level":1,"score":0.4515591263771057},{"id":"https://openalex.org/C47344431","wikidata":"https://www.wikidata.org/wiki/Q1519812","display_name":"Health policy","level":3,"score":0.423061341047287},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35064589977264404},{"id":"https://openalex.org/C121955636","wikidata":"https://www.wikidata.org/wiki/Q4116214","display_name":"Accounting","level":1,"score":0.3346259593963623},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.3275546729564667},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3039069175720215},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.2583864629268646},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.18683528900146484},{"id":"https://openalex.org/C105639569","wikidata":"https://www.wikidata.org/wiki/Q582577","display_name":"Economic policy","level":1,"score":0.16199246048927307},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.13142678141593933},{"id":"https://openalex.org/C175444787","wikidata":"https://www.wikidata.org/wiki/Q39072","display_name":"Microeconomics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:14064228","doi":null,"is_oa":false,"landing_page_url":"https://ec.europa.eu/DocsRoom/documents/7607/attachments/1/translations/en/renditions/pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W2115740217"],"related_works":["https://openalex.org/W2805734200","https://openalex.org/W2081169940","https://openalex.org/W2085399204","https://openalex.org/W2617289888","https://openalex.org/W2522265942","https://openalex.org/W2015443986","https://openalex.org/W2588719184","https://openalex.org/W2944150858","https://openalex.org/W2206493351","https://openalex.org/W2038390083"],"abstract_inverted_index":{"page":[0],"List":[1,7],"of":[2,8],"tables":[3],"and":[4,13,28,66,106],"boxes":[5],"4":[6],"abbreviations":[9],"5":[10],"1.":[11],"Background":[12,42,76,89],"objective":[14],"6":[15],"2.":[16],"Tender":[17,98],"systems":[18,99],"for":[19,47,100,108],"pharmaceuticals":[20],"in":[21,38,86,94],"EU":[22],"Member":[23],"States":[24],"8":[25],"3.":[26],"Data":[27],"Methods":[29],"13":[30],"4.":[31],"Results":[32],"15":[33,41,43,52],"4.1.":[34],"The":[35,44,71,78,83,91,137],"Preference":[36,60],"Policy":[37,61,80],"the":[39],"Netherlands":[40],"\u201cTransition":[45],"Agreement\u201d":[46],"pharmaceutical":[48],"healt":[49],"hcare":[50],"2008-2009":[51],"Pharmaceutical":[53],"preference":[54,64],"policy":[55,65,93],"16":[56,62],"Joint":[57],"or":[58],"Collective":[59],"Individual":[63],"its":[67],"effect":[68],"17":[69],"4.2.":[70],"German":[72],"Rebate":[73,79],"System":[74],"20":[75,77,81],"4.3.":[82],"tender":[84,92],"system":[85],"Belgium":[87],"23":[88,90,96],"practice":[95],"5.":[97],"ambulatory":[101],"care":[102],"drugs:":[103],"Impact":[104],"on":[105],"implications":[107],"stakeholders":[109],"25":[110,114],"5.1.":[111],"Sickness":[112],"funds":[113],"5.2.":[115],"Patients":[116],"26":[117,120,123],"Direct":[118],"benefits":[119,122],"Indirect":[121],"5.3.":[124],"Physicians":[125],"27":[126,129,132],"5.4.":[127],"Pharmacies":[128],"Pharmacy":[130],"remuneration":[131],"Incentive":[133],"structure":[134],"28":[135],"5.5.":[136],"generics":[138],"industry":[139],"29":[140]},"counts_by_year":[{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":9}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}